Shanghai Haixin Group Co Ltd B (900917) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Haixin Group Co Ltd B (900917) has a cash flow conversion efficiency ratio of 0.002x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.56 Million) by net assets ($4.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Shanghai Haixin Group Co Ltd B to measure how many days the company can operate on defensive assets alone.
Shanghai Haixin Group Co Ltd B - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Shanghai Haixin Group Co Ltd B's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Haixin Group Co Ltd B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Haixin Group Co Ltd B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
One and One Green Technologies. Inc Class A Ordinary Shares
NASDAQ:YDDL
|
N/A |
|
Caisse Régionale du Crédit Agricole Alpes Provence
PA:CRAP
|
0.041x |
|
Innoviz Technologies
NASDAQ:INVZ
|
-0.153x |
|
Onde SA
WAR:OND
|
0.026x |
|
Rav Bariach 08 Industries Ltd
TA:BRIH
|
0.051x |
|
RumbleON Inc
NASDAQ:RMBL
|
-2.319x |
|
DAE HWA Pharmaceutical Co. Ltd
KQ:067080
|
0.004x |
|
Astra Graphia Tbk
JK:ASGR
|
0.006x |
Annual Cash Flow Conversion Efficiency for Shanghai Haixin Group Co Ltd B (2015–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Haixin Group Co Ltd B from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 900917 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.92 Billion | $117.69 Million | 0.024x | +38.99% |
| 2024-12-31 | $4.50 Billion | $77.52 Million | 0.017x | +298.48% |
| 2023-12-31 | $4.14 Billion | $-35.88 Million | -0.009x | -147.41% |
| 2022-12-31 | $4.02 Billion | $73.56 Million | 0.018x | -64.31% |
| 2021-12-31 | $4.28 Billion | $219.65 Million | 0.051x | +83.35% |
| 2020-12-31 | $4.38 Billion | $122.50 Million | 0.028x | +535.28% |
| 2019-12-31 | $4.05 Billion | $-26.02 Million | -0.006x | -141.97% |
| 2018-12-31 | $3.63 Billion | $55.50 Million | 0.015x | +354.26% |
| 2017-12-31 | $3.95 Billion | $13.31 Million | 0.003x | +173.71% |
| 2016-12-31 | $4.34 Billion | $-19.84 Million | -0.005x | +81.37% |
| 2015-12-31 | $4.80 Billion | $-117.88 Million | -0.025x | -- |
About Shanghai Haixin Group Co Ltd B
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothi… Read more